[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"spine-deformity\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:spine-deformity":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,53,84,113,143,172,201],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":33,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100444723","advanced-spinal-innovations-with-robotics-and-enabling-technology-registry-100444723",false,"NCT05071144","Advanced SPinal Innovations With Robotics and Enabling Technology Registry","ASPIRE","Inclusion Criteria:\n\n* Diagnosis of a spine deformity\n* Scheduled for surgery using robotics and navigation and\u002For patient-specific rods\n* Up to and including 21 years of age\n* Speak and read English or Spanish\n\nExclusion Criteria:\n\n• None",true,"ALL","0 Years","21 Years",{"count":21,"type":22},700,"ESTIMATED","5 Years","OBSERVATIONAL","Creation of a pediatric robotic spine surgery registry will allow for data collection and analysis on the coupled use of robotics and navigation, as well as patient-specific rods in pediatric spine deformity surgery across participating study institutions. Eventually, an educational and informative framework for this technology will be established.",[27,28,29,30,31,32],"Spine Deformity","Idiopathic Scoliosis","Adolescent Idiopathic Scoliosis","Spondylolisthesis","Congenital Scoliosis","Neuromuscular Scoliosis",[34,35,36,37,38,39],"Pediatric","Spine","Surgery","Registry","Robotic","Navigation","RECRUITING","2026-06-18",{"date":43,"type":44},"2026-06-22","ACTUAL",{"date":46,"type":44},"2021-12-13",{"date":48,"type":22},"2031-12",{"name":50,"class":51},"Boston Children's Hospital","OTHER",10,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":4,"eligibilityCriteria":59,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":64,"studyType":24,"phases":4,"briefSummary":65,"conditions":66,"keywords":69,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":83},"100628266","the-effect-of-peloidotherapy-in-young-adults-undergoing-physical-therapy-scoliosis-specific-exercises-psse-100628266","NCT07459400","The Effect of Peloidotherapy in Young Adults Undergoing Physical Therapy Scoliosis Specific Exercises (PSSE)","The Effect of Peloidotherapy on Pain and Quality of Life in Young Adult Individuals With Scoliosis Undergoing Physiotherapy Scoliosis-Specific Exercises (PSSE)","Inclusion Criteria:\n\n* Aged 20-40 years\n* Diagnosed with idiopathic scoliosis by a specialist physician\n* Cobb angle between 15-40 degrees\n* Able to perform PSSE exercises throughout the study period\n* VAS ≥3 at the start of the study\n* Has had pain complaints for at least 3 months\n* Individuals who have agreed in writing to participate in the study\n\nExclusion Criteria:\n\n* Individuals who have undergone scoliosis surgery\n* Individuals with neuromuscular, congenital, or secondary scoliosis\n* Individuals with rheumatological, inflammatory, or serious chronic diseases (such as cardiopulmonary insufficiency or kidney disease)\n* Pregnant and breastfeeding women\n* Conditions in which peloidotherapy is contraindicated (active skin infection, open wound, serious dermatological disease, history of allergic reaction, severe cardiopulmonary, kidney or liver failure, bleeding disorder or anticoagulant use, pregnancy\u002Fbreastfeeding, and systemic infection)\n* Individuals with serious psychiatric disorders that may interfere with treatment compliance or affect consent\n* Individuals receiving additional physical therapy during the study period","20 Years","40 Years",{"count":63,"type":22},54,"4 Months","Scoliosis is a musculoskeletal disorder defined by a three-dimensional spinal deformity that can result in substantial clinical and functional limitations, particularly during adolescence and young adulthood. Affected individuals commonly experience postural asymmetry, muscular imbalance, pain, and diminished quality of life. In conservative management, Physiotherapeutic Scoliosis-Specific Exercises (PSSE) have gained recognition as a fundamental intervention. The primary objectives of PSSE include optimizing spinal alignment, facilitating rotational breathing, and restoring muscular symmetry to improve functional capacity. Evidence from systematic reviews suggests that PSSE, especially the Schroth method, are superior to general exercise programs in improving both radiographic parameters and health-related quality of life.Meta-analytic findings further support the effectiveness of PSSE in reducing curve magnitude and enhancing quality of life outcomes. Among the various PSSE approaches, the Schroth method is one of the most extensively investigated and widely applied in clinical settings. This method incorporates three-dimensional postural correction, targeted breathing techniques, and the development of postural awareness. Randomized controlled trials have demonstrated that Schroth exercises significantly improve SRS-22 quality of life scores and positively influence pain, body image, and overall well-being.Despite these established benefits, pain and muscle tension occurring during exercise sessions may negatively influence adherence to rehabilitation programs. In young adults, pain is a critical factor limiting treatment compliance and restricting engagement in daily activities. Accordingly, adjunctive interventions implemented prior to exercise may enhance exercise tolerance and optimize therapeutic outcomes.Peloidotherapy, which involves the therapeutic application of natural medicinal mud, is commonly used in musculoskeletal rehabilitation due to its analgesic, muscle-relaxant, and circulation-enhancing effects. By alleviating pain and reducing muscular tension, peloidotherapy may facilitate greater participation in exercise programs and support improved clinical outcomes.This study aims to investigate the effects of adjunctive peloidotherapy administered before Schroth-based PSSE in young adults with scoliosis, focusing on pain, exercise adherence, and quality of life, with particular emphasis on SRS-22 measures..",[27,67,68],"Adult Scoliosis","Peloidotherapy",[68,67,70,71,72],"Physiotherapy Scoliosis-Specific Exercises (PSSE)","Pain","Quality of Life","2026-06-08",{"date":75,"type":44},"2026-06-10",{"date":77,"type":44},"2026-03-23",{"date":79,"type":22},"2026-10-23",{"name":81,"class":82},"Gaziosmanpasa Research and Education Hospital","OTHER_GOV",1,{"id":85,"slug":86,"hasResults":11,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":11,"sex":17,"minAge":92,"maxAge":4,"enrollmentInfo":93,"targetDuration":4,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":112},"100505825","study-of-an-intrathecal-port-and-catheter-system-for-subjects-with-spinal-muscular-atrophy-100505825","NCT05866419","Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy","Safety and Performance of the ThecaFlex DRx™ System Port and Catheter for Chronic Intrathecal Access, Cerebrospinal Fluid (CSF) Aspiration, and DElivery of Nusinersen in Spinal Muscular Atrophy (SMA) Patients Resistant to Lumbar PunctuRE Trial (PIERRE)","PIERRE","Inclusion Criteria:\n\n1. Subject is 3 years or older\n2. Subject diagnosed with SMA who are candidates for Spinraza treatment as indicated in its label\n3. Subject resistant to lumbar puncture (LP), where resistance is defined as:\n\n   1. Subject with respiratory issues or other comorbidities who is at an increased risk for complications due to the need for repeat anesthesia and imaging radiation exposure to safely perform LP; or\n   2. Subjects for whom the treating physician determines implantation of the ThecaFlex DRx™ System is otherwise in the subject's best interest\n4. Subject has been prescribed nusinersen via chronic intrathecal bolus administration in accordance with the drug labeling and first port access of the ThecaFlex DRx system is planned within 2 weeks of implantation\n5. Subject, per Investigator discretion, is able to undergo a percutaneous or open surgical procedure for index port and catheter implantation where at least 7 cm of the ThecaFlex DRx system catheter will be placed intrathecally\n6. Subject (or subject's legally authorized representative) is willing and able to provide written informed consent; and\n7. Subject and parent\u002Fcaregiver able and willing to complete all clinical investigation procedures, measurements, and visits.\n\nExclusion Criteria:\n\n1. Subject meets any of the contraindications for use of the ThecaFlex DRx™ System as outlined in the ThecaFlex DRx™ System Instructions for Use\n2. Presence or history of (\\\u003C 6 months prior to the procedure): an implanted microinfusion pump, intrathecal catheter, or other intrathecal drug delivery devices\u002Fcomponent, or implanted shunt for drainage of cerebrospinal fluid (CSF), or reservoir in the CSF space (note: any ThecaFlex Port and Catheter System must not be placed in the same location as a previous indwelling port and catheter)\n3. Subject is pregnant or nursing or plans to become pregnant during the course of the clinical investigation\n4. Any condition or event, which in the opinion of the Investigator may adversely affect the safety and effective implantation and use of the ThecaFlex DRx™ system or confound the clinical investigation, including:\n\n   1. Severe structural impediment that may preclude safe implantation of the catheter and port\n   2. Major medical events within 60 days prior to screening; or\n   3. Relevant surgeries (e.g., head and neck, back, etc.) within 60 days prior to screening or planned during the duration of the clinical investigation\n   4. Space-occupying lesion with mass effect\n   5. Posterior fossa mass\n   6. Arnold-Chiari malformation\n   7. Coagulation abnormalities and\u002For thrombocytopenia\n   8. Insufficient or inadequate skin or underlying fat to adequately protect the port or enough surface area to allow the skin to close safely\n5. Subject is contraindicated for administration of nusinersen per its approved labeling\n6. History of intrathecal granuloma formation\n7. History of bacterial meningitis or aseptic meningitis within 6 months of screening\n8. History of tumors or other spinal abnormalities documented by magnetic resonance imaging (MRI) or computed tomography (CT) that would interfere with the catheter implantation procedures or CSF circulation\n9. History of hydrocephalus\n10. Diagnosed degenerative muscular disease other than SMA\n11. History of depression, cognitive impairment, or another psycho-behavioral problem that in the opinion of the Investigator may preclude safe participation in the clinical investigation and\n12. Serious medical condition that, in the opinion of the investigator, may lead to reduced life expectancy beyond 12 months.\n13. Subject is involved in another Investigation Device Exemption Study.","3 Years",{"count":94,"type":22},90,"INTERVENTIONAL",[97],"NA","The primary objective of the clinical investigation is to demonstrate successful clinical use of the ThecaFlex DRx™ System in delivering nusinersen in subjects with spinal muscular atrophy (SMA).\n\nAll enrolled subjects will undergo implantation of the investigational device (ThecaFlex DRx™ System) and will be followed for 12 months after receiving the implant. The 12-month data will be used to assess the primary endpoint support a Pre-Market Approval (PMA) application.",[100,27,101],"Spinal Muscular Atrophy","Scoliosis","2026-04-14",{"date":104,"type":44},"2026-04-16",{"date":106,"type":44},"2023-11-27",{"date":108,"type":22},"2030-07",{"name":110,"class":111},"Alcyone Therapeutics, Inc","INDUSTRY",21,{"id":114,"slug":115,"hasResults":11,"nctId":116,"briefTitle":117,"officialTitle":117,"acronym":4,"eligibilityCriteria":118,"healthyVolunteers":11,"sex":17,"minAge":119,"maxAge":120,"enrollmentInfo":121,"targetDuration":4,"studyType":95,"phases":123,"briefSummary":124,"conditions":125,"keywords":130,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":83},"100613036","the-effect-of-three-dimensional-exercises--schroth-method--on-trunk-muscle-endurance-sleep-quality-and-quality-of-life-in-adolescents-with-hyperkyphosis-100613036","NCT07261358","The Effect of Three-Dimensional Exercises ( Schroth Method ) on Trunk Muscle Endurance, Sleep Quality, and Quality of Life in Adolescents With Hyperkyphosis","Inclusion Criteria:\n\n* Adolescents between 12 and 18 years of age\n* Presence of thoracic kyphosis with a T3-T12 Cobb angle ≥45° measured on a lateral thoracic radiograph\n* Sufficient physical and cognitive ability to actively participate in the exercise protocol for at least 3 months\n* Adequate communication and cognitive capacity to understand the educational materials provided\n* Ability and willingness to regularly complete the exercise log throughout the study period\n\nExclusion Criteria:\n\n* Scoliosis with a Cobb angle \\>10° in the coronal plane\n* Presence of structural spinal deformities such as vertebral fracture, spondylolisthesis\n* History of previous spinal surgery\n* Neuromuscular disorders that may affect the spine (e.g., cerebral palsy, muscular dystrophy)\n* Structural or functional pathologies involving the spine, pelvic complex, or shoulder girdle\n* Balance disorders such as vestibular dysfunction, vertigo, or other conditions affecting postural control\n* Inability to comply with the exercise protocol due to intellectual disability, severe behavioral disorders, or significant communication impairments\n* Participation in professional-level sports activities that may influence exercise capacity or musculoskeletal function\n* Presence of serious cardiopulmonary diseases (e.g., congenital heart disease, pulmonary hypertension)","12 Years","18 Years",{"count":122,"type":22},60,[97],"Adolescence is a critical period for spinal growth, and progression of thoracic hyperkyphosis may lead to pain, weak trunk muscles, sleep disturbances, and reduced quality of life. This study aims to investigate the effects of three-dimensional exercise program based on the Schroth Method on trunk muscle endurance, thoracic kyphosis angle, pain, sleep quality and quality of life in adolescents aged 12-18 years with hyperkyphosis.",[27,126,127,128,129],"Kyphosis","Adolescent","Sleep Quality","Trunk Muscle Endurance",[131,132,133,134],"postural kyphosis","sleep quality","trunk muscle endurance","adolescent spine deformity","2026-02-08",{"date":137,"type":44},"2026-02-11",{"date":139,"type":44},"2025-10-06",{"date":141,"type":22},"2026-05-01",{"name":81,"class":82},{"id":144,"slug":145,"hasResults":11,"nctId":146,"briefTitle":147,"officialTitle":147,"acronym":4,"eligibilityCriteria":148,"healthyVolunteers":16,"sex":17,"minAge":149,"maxAge":150,"enrollmentInfo":151,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":153,"conditions":154,"keywords":155,"overallStatus":162,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":166,"completionDateStruct":168,"leadSponsor":170,"locationsCount":4},"100575877","implementation-of-momentum-spinetm-a-new-3d-imaging-software-for-idiopathic-scoliosis-100575877","NCT06777992","Implementation of Momentum SpineTM: a New 3D Imaging Software for Idiopathic Scoliosis","Inclusion Criteria:\n\n* Children aged between 8 and 14 with a confirmed radiographic diagnosis of Idiopathic Scoliosis who have not undergone spinal nor thoracic surgery.\n\nExclusion Criteria:\n\n* Patients who may be pregnant. Patients with the existence of a second deformity, or any other neuromuscular condition.","8 Years","14 Years",{"count":152,"type":22},142,"Brief Summary\n\nThe goal of this clinical trial is to evaluate the implementation of Momentum Spine™, a new 3D imaging software designed to improve the monitoring and management of idiopathic scoliosis in children aged 8-14 years. Idiopathic scoliosis affects 1-3% of the pediatric population and is currently monitored through hospital visits with radiographic imaging every 4-6 months, which exposes patients to cumulative radiation over time. This study explores whether Momentum Spine™ can provide a safer, more accessible alternative by enabling at-home monitoring using clinical photographs taken on smartphones.\n\nThe primary questions this study seeks to answer are:\n\nCan Momentum Spine™ accurately predict scoliosis progression, including Cobb angle changes, compared to standard radiographic assessments? Can the use of Momentum Spine™ reduce the number of X-rays required and improve the timing of clinical follow-ups? Does the use of Momentum Spine™ affect patient satisfaction, healthcare utilization, and overall quality of life? This study is a prospective, two-arm randomized controlled trial conducted at CHU Sainte-Justine. Participants will be divided into two groups: the control group will receive standard care, which involves regular clinical visits and radiographic evaluations; the intervention group will use Momentum Spine™ at home, alongside standard care.\n\nIntervention Details\n\nParticipants in the intervention group will:\n\nUse the Momentum Spine™ application to capture 3D images of their torso at home every two months. These images will be processed by Momentum Spine™ algorithms to assess curve progression.\n\nParticipants will receive notifications and guidance on performing scans at home, supported by the study team to ensure accuracy.\n\nThe primary outcomes include clinical measures such as changes in Cobb angle at 1 and 2 years, curve progression of more than 5 degrees, whether the main curve reaches 45 degrees, and the need for surgical referral. Secondary outcomes focus on the accuracy, sensitivity, and specificity of Momentum Spine™, as well as patient-reported measures such as health-related quality of life and satisfaction with care, users' acceptability of the software, healthcare services utilization and pathway costs.\n\nThis study also aims to address key challenges in scoliosis care, including reducing radiation exposure, improving follow-up timing to align with growth spurts, and providing equitable access to care for families who may live far from specialty clinics. By validating the performance of Momentum Spine™, this trial has the potential to transform scoliosis management, ensuring safer and more effective care pathways.",[27,28],[156,157,158,159,160,161],"Idiopathic scoliosis","Screening","Spine deformity","Progression","Non-invasive 3D scans","Pediatrics","NOT_YET_RECRUITING","2025-01-10",{"date":165,"type":44},"2025-01-16",{"date":167,"type":22},"2025-03",{"date":169,"type":22},"2028-12",{"name":171,"class":51},"St. Justine's Hospital",{"id":173,"slug":174,"hasResults":11,"nctId":175,"briefTitle":176,"officialTitle":177,"acronym":4,"eligibilityCriteria":178,"healthyVolunteers":16,"sex":17,"minAge":120,"maxAge":179,"enrollmentInfo":180,"targetDuration":4,"studyType":95,"phases":182,"briefSummary":183,"conditions":184,"keywords":185,"overallStatus":162,"whyStopped":4,"lastUpdateSubmitDate":192,"lastUpdatePostDateStruct":193,"startDateStruct":195,"completionDateStruct":197,"leadSponsor":199,"locationsCount":83},"100533278","spine-deformity-patients-with-optoelectronic-motion-capture-100533278","NCT06223737","Spine Deformity Patients With Optoelectronic Motion Capture","Characterization of Patients Suffering From Adult Spine Deformities With Optoelectronic Motion Analysis","Inclusion Criteria:\n\n* both male and female subjects\n* BMI \\\u003C 30 kg\u002Fm2\n* cognitively intact\n* degenerative spinal deformity presenting with at least one criterion:\n\n  * Coronal Cobb angle ≥20°\n  * sagittal vertical axis (SVA) ≥5 cm\n  * thoracic kyphosis (TK) ≥60°\n  * pelvic tilt (PT) ≥25°.\n\nExclusion Criteria:\n\n* age under 18 years or over 75 years\n* any prior spinal surgery or other musculoskeletal surgery having an impact on movement\n* pregnancy\n* inability to perform the planned set of daily activities\n* inability to give consent.","75 Years",{"count":181,"type":22},30,[97],"Aging-induced changes in the spine can lead to adult spinal deformity, causing a forward and\u002For lateral shift of the trunk. While mild cases may have compensatory mechanisms, severe deformities necessitate treatment. Surgery with instrumentation effectively corrects deformities, but complications are common. Precise pre-operative planning based on X-rays is essential. However, radiological imaging has limitations, including ionizing radiation exposure and static nature. Marker-based optoelectronic motion analysis systems offer potential benefits for dynamic spine assessment.\n\nThis study aims to test the feasibility of using motion analysis systems to characterize spinal alignment and balance in patients with adult spine deformity. The primary objective is to assess the practical implementation, measurement capability, and resources required for motion analysis. Secondary objectives include investigating errors in absolute spinal curvature assessment and developing compensation strategies.\n\nThe project will recruit 20 patients (non-operated and operated) seeking medical attention for adult spine deformities and 10 healthy controls. Participants will undergo biplanar imaging and motion analysis to capture static and dynamic spine alignment during common activities. The data will help build patient-specific musculoskeletal models, offering potential insights into improving surgical planning for adult spine deformities.",[27],[186,187,188,189,190,191],"Adult Spine Deformity","Surgical Planning","Spinal Deformity","Optoelectronic Motion Analysis","Biplanar Radiography","Absolute Spinal Curvature","2024-11-26",{"date":194,"type":44},"2024-11-29",{"date":196,"type":22},"2025-05-01",{"date":198,"type":22},"2026-12-30",{"name":200,"class":51},"Schulthess Klinik",{"id":202,"slug":203,"hasResults":11,"nctId":204,"briefTitle":205,"officialTitle":205,"acronym":4,"eligibilityCriteria":206,"healthyVolunteers":11,"sex":17,"minAge":120,"maxAge":4,"enrollmentInfo":207,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":209,"conditions":210,"keywords":214,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":220,"lastUpdatePostDateStruct":221,"startDateStruct":223,"completionDateStruct":225,"leadSponsor":227,"locationsCount":229},"100460469","evaluation-of-the-ifuse-bedrock-technique-in-association-with-posterior-lumbosacral-fusion-with-iliac-fixation-100460469","NCT05276024","Evaluation of the IFuse Bedrock Technique in Association with Posterior Lumbosacral Fusion with Iliac Fixation.","Inclusion Criteria:\n\n* Subject scheduled for open posterior lumbosacral arthrodesis (including at least the following three vertebrae: L4, L5 and S1) associated with a sacroiliac fusion procedure and iliac fixation (thoracolumbar fusion procedures extended to sacrum are eligible in the study);\n* Insertion of at least 1 iFuse-3D implant according to the iFuse Bedrock technique (uni- and bilateral insertion are eligible);\n* Subject who preoperatively responded positively to pain provocation tests for SIJ dysfunction with or without a positive SIJ infiltration test;\n* Patient with a degenerative sacroiliac joint disease requested a fusion procedure;\n\nExclusion Criteria:\n\n* Major osteoporosis (DEXA scan \\> 3);\n* Any previous history of sacroiliac joint fusion or any surgical procedure involving a S2-iliac fusion;\n* Subjects requested a SIJ fusion without the iFuse-3D device or iFuse-3D not inserted according to the manufacturer instruction (Bedrock technique);\n* Subjects with a medical or surgical contraindication preventing the intervention from being performed or potentially interfering in the interpretation of the data collected (neurologic condition, local or systemic infection, any known allergy to surgical implants, psychiatric diseases, ...);\n* Currently pregnant or planning pregnancy;\n* Prisoner or a ward of the state;\n* Subject no willing to participate in the study;\n* Subject not affiliated to a social security insurance.",{"count":208,"type":22},50,"The purpose of this study is to describe the impact of the iFuse Bedrock technique to decrease post-operative pains in patients who underwent multilevel posterior lumbosacral fusion.",[211,212,213,27],"Sacroiliitis","Sacroiliac; Fusion","Lumbosacral; Fusion",[215,216,217,218,219],"Sacroiliac joint pain","Sacroiliac joint fusion","Bedrock technique","Open posterior lumbosacral fusion","Spine deformties","2024-11-06",{"date":222,"type":44},"2024-11-08",{"date":224,"type":44},"2022-06-10",{"date":226,"type":22},"2026-04-01",{"name":228,"class":51},"Polyclinique Bordeaux Nord Aquitaine",2]